GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppressionDilan Athauda, Sonia Gandhi, Laura Mahoney‐Sanchez et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 7